Filing Flows › Vycor Medical (VYCO) › Q1 2026 › vs Q1 2025
Vycor Medical (VYCO) Q1 2026 vs Q1 2025 (year over year)
Vycor Medical's revenue rose $22K (+5%) from $436K in Q1 2025 to $459K in Q1 2026. The biggest changes: Vycor Medical Inc +$22K (+5%); Nova Vision Inc +$241 (+1%). Gross margin 81.8% against 82.2% (-0.3 pts).
Vycor Medical, Q1 2026: revenue $459K (+5% year over year), operating margin 10.0%, net earnings $20K, operating cash flow $99K. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Gross margin | 81.8% | 82.2% | -0.3 pts |
| Operating margin | 10.0% | -2.9% | +12.9 pts |
| Net margin | 4.4% | -8.8% | +13.2 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Vycor Medical Inc | $440K | $419K | $22K | +5% |
| Nova Vision Inc | $18K | $18K | $241 | +1% |
| Revenue | $459K | $436K | $22K | +5% |
| Gross profit | $375K | $359K | $17K | +5% |
| Cost of revenue | $83K | $78K | $6K | +7% |
| Operating profit | $46K | −$13K | $59K | — |
| Operating expenses | $329K | $371K | −$42K | -11% |
| Pre-tax earnings | $20K | −$39K | $59K | — |
| Other expense, net | $26K | $26K | $5 | 0% |
| SG&A | $315K | $351K | −$35K | -10% |
| Other operating costs | $14K | $15K | −$1K | -6% |
| Income tax benefit | $13 | −$49 | $62 | — |
| Net earnings | $20K | −$39K | $59K | — |
| Depreciation & amortization | $14K | $15K | −$1K | -6% |
| Working capital & other | $65K | −$22K | $87K | — |
| Operating cash flow | $99K | −$27K | $126K | — |
Questions
How much did Vycor Medical's revenue grow year over year in Q1 2026?
Vycor Medical's revenue rose $22K (+5%) from $436K in Q1 2025 to $459K in Q1 2026.
What drove Vycor Medical's revenue change in Q1 2026?
Vycor Medical Inc +$22K (+5%); Nova Vision Inc +$241 (+1%).